Research out of the University of New Hampshire shows that communities that were easier for people to lace up and get out for a walk during the COVID-19 pandemic also helped lower the impact of […]
Brucellosis is a serious and often neglected disease endemic to many low- and middle-income countries around the world. Because it shares many of the same clinical symptoms as malaria—including fever and joint pain—it can be […]
Scientists at St. Jude Children’s Research Hospital demonstrated for the first time that the protein midkine plays a preventative role against Alzheimer’s disease. Midkine is known to accumulate in Alzheimer’s disease patients. Now, researchers have […]
The COVID-19 virus hijacks the machinery of testicular cells that produce the hormone testosterone in order to replicate. It also appropriates the metabolic pathways of these cells and cholesterol, a precursor of testosterone, thereby altering […]
More than 30 million Americans rely on implanted medical devices like prosthetic joints, pacemakers and more to improve their quality of life. But implanting any foreign object into the body also carries the risk of […]
Breast cancer patients who participated in a remote weight loss intervention program lost an average of 4.7% of their baseline body weight after one year, while those in the education only control group gained an […]
A team of researchers at the University of Cologne’s Center for Biochemistry, together with the Bambino Gesù Pediatric Hospital in Rome, Italy, have discovered a fundamental biological mechanism that directly connects the immune sensor protein […]
An artificial intelligence (AI)-assisted model that combines a patient’s MRI, biochemical, and clinical information shows preliminary promise in improving predictions of whether their knee osteoarthritis may soon worsen. Ting Wang of Chongqing Medical University, China, […]
The global incidence of autoimmune diseases among children has increased over the past few decades. A study published in the open-access journal PLOS Medicine by Ju-Young Shin at Sungkyunkwan University, Republic of Korea, and colleagues […]
The U.S. Food and Drug Administration has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca